Our Recent Projects

Completed Project andrew Durand Completed Project andrew Durand

PREVENTION Platform

Developed and tested an e-health platform to support women during breast cancer genetic testing. The platform was highly rated, and allowed users to follow screening recommendations, track appointments, and access personalized information on breast cancer risk and lifestyle impacts.

Read More
Completed Project andrew Durand Completed Project andrew Durand

Perspective Study

Dr. Loiselle’s lab joined Dr. Jacque Simard’s team at l’Université Laval in a Génome Québec-funded study to evaluate a website that educated women on genetic and lifestyle risk factors for breast cancer. The team assessed community perceptions and the acceptability of this information.

Read More
Completed Project andrew Durand Completed Project andrew Durand

Being Known Qualitative Study

Past research focused on physician-patient communication, with less attention to the nurse-patient relationship and its impact on patients feeling “known” in healthcare. This study explored cancer patients' experience of “being known” in ambulatory care settings where nursing rounds had been implemented, highlighting the importance of nurse-patient communication.

Read More
Breast & Bone Health Project
Completed Project andrew Durand Completed Project andrew Durand

Breast & Bone Health Project

Some women with breast cancer were at higher risk for bone fragility due to treatment. Hope & Cope and the Segal Cancer Centre led a program to promote bone health, resulting in a comprehensive toolkit for integrating bone health practices into breast cancer treatment across Quebec.

Read More
Coping Together
Completed Project andrew Durand Completed Project andrew Durand

Coping Together

Hematopoietic stem cell transplantations (HSCTs) shifted from inpatient to outpatient settings, increasing caregiver (CG) involvement. This study adapted the Coping Together (CT) manuals for HSCT patients and CGs, exploring their perceptions and adaptation to enhance coping during the first 100 days post-HSCT at Memorial Sloan-Kettering Cancer Center.

Read More